Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020

This cross-sectional study of a sample of healthy adults assesses the seroprevalence of SARS-CoV-2 antibodies in the US asymptomatic population as of September 30, 2020.

Detalles Bibliográficos
Autores principales: Stout, Robert L., Rigatti, Steven J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967079/
https://www.ncbi.nlm.nih.gov/pubmed/33724387
http://dx.doi.org/10.1001/jamanetworkopen.2021.1552
_version_ 1783665796512219136
author Stout, Robert L.
Rigatti, Steven J.
author_facet Stout, Robert L.
Rigatti, Steven J.
author_sort Stout, Robert L.
collection PubMed
description This cross-sectional study of a sample of healthy adults assesses the seroprevalence of SARS-CoV-2 antibodies in the US asymptomatic population as of September 30, 2020.
format Online
Article
Text
id pubmed-7967079
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-79670792021-04-01 Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020 Stout, Robert L. Rigatti, Steven J. JAMA Netw Open Research Letter This cross-sectional study of a sample of healthy adults assesses the seroprevalence of SARS-CoV-2 antibodies in the US asymptomatic population as of September 30, 2020. American Medical Association 2021-03-16 /pmc/articles/PMC7967079/ /pubmed/33724387 http://dx.doi.org/10.1001/jamanetworkopen.2021.1552 Text en Copyright 2021 Stout RL et al. JAMA Network Open. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the CC-BY-NC-ND License.
spellingShingle Research Letter
Stout, Robert L.
Rigatti, Steven J.
Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020
title Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020
title_full Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020
title_fullStr Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020
title_full_unstemmed Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020
title_short Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020
title_sort seroprevalence of sars-cov-2 antibodies in the us adult asymptomatic population as of september 30, 2020
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967079/
https://www.ncbi.nlm.nih.gov/pubmed/33724387
http://dx.doi.org/10.1001/jamanetworkopen.2021.1552
work_keys_str_mv AT stoutrobertl seroprevalenceofsarscov2antibodiesintheusadultasymptomaticpopulationasofseptember302020
AT rigattistevenj seroprevalenceofsarscov2antibodiesintheusadultasymptomaticpopulationasofseptember302020

Ejemplares similares